Answers are grounded in this paper and cite their sources.
We read with interest the “Perspective” by Cirulis et al . and the accompanying editorial by Pakshirajan, both of which discuss our recent publication analyzing the effect of anticoagulation with warfarin in patients with pulmonary arterial hypertension (PAH) enrolled in the REVEAL registry (1).
No takes yet. Share an insight, caveat, or question.
Preston et al. (2016) conducted an editorial in Pulmonary arterial hypertension. Anticoagulation was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: